A histo-immunopathologic and prognostic study of erythrodermic cutaneous T-cell lymphoma

被引:4
|
作者
Vonderheid, Eric C. [1 ]
Kantor, Gary R. [2 ]
Telang, Gladys H. [3 ]
Bujanouskas, Paul [4 ]
Kadin, Marshall E. [5 ,6 ]
机构
[1] Johns Hopkins Med Inst, Sydney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA
[2] Inst Dermatopathol, Dermpath Diagnost, Newtown Sq, PA USA
[3] Brown Univ, Warren Alpert Med Sch, Dept Dermatol, Providence, RI 02912 USA
[4] Midatlantic Permanente Med Grp, Falls Church, VA USA
[5] Boston Univ, Dept Dermatol, Providence, RI USA
[6] Roger Williams Med Ctr, Providence, RI USA
关键词
CD62L; cutaneous T-cell lymphoma; mycosis fungoides; prognosis; Sezary syndrome; SEZARY-SYNDROME; MYCOSIS-FUNGOIDES; INTERNATIONAL-SOCIETY; EUROPEAN-ORGANIZATION; TASK-FORCE; RESPONSE CRITERIA; EXPRESSION; CLASSIFICATION; LYMPHOCYTES; PHENOTYPES;
D O I
10.1111/cup.13564
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Sezary syndrome (SS) and erythrodermic mycosis fungoides (E-MF) represent two expressions of erythrodermic cutaneous T-cell lymphoma (E-CTCL). Methods Histopathologic features were compared on skin specimens from 41 patients with SS and 70 patients with E-MF. Immunopathologic findings were compared on 42 SS and 79 E-MF specimens. Results Specimens of SS usually showed band-like dermal infiltrates with intermediate-sized lymphoid cells and few plasma cells; on the other hand E-MF more often had a perivascular infiltrative pattern, predominance of small/mixed lymphoid cells and eosinophils. SS also had lower numbers of CD8+ cells and higher numbers of CD62L+ cells compared to E-MF. For E-MF patients, the presence of large Pautrier collections, infiltrates with intermediate-sized cells, increased number of mitotic figures and >= 50% CD62L+ cells in the dermal infiltrate correlated with a relatively poor disease-specific survival. However, only the presence of mitotic figures retained prognostic significance with clinical stage as a covariate. Conclusions Clinical stage provides the most important prognostic information for patients with E-CTCL. However, mitotic activity for E-MF and CD8+ cells <20% for SS have additional value. We hypothesize that observed differences in plasma cell and eosinophil numbers may reflect the influence of CD62L+ central memory T-cells in the microenvironment.
引用
收藏
页码:913 / 924
页数:12
相关论文
共 50 条
  • [1] Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma
    Vidulich, Kelley A.
    Talpur, Rakhshandra
    Bassett, Roland L.
    Duvic, Madeleine
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (03) : 243 - 252
  • [2] Overall survival in erythrodermic cutaneous T-cell lymphoma: An analysis of prognostic factors in a cohort of erythrodermic cutaneous T-cell lymphoma patients
    Vidulich, Kelley A.
    Talpur, Rakhshandra
    Bassett, Roland L.
    Duvic, Madeleine
    BLOOD, 2007, 110 (11) : 1045A - 1045A
  • [3] Erythrodermic syringotropic cutaneous T-cell lymphoma
    Ah-Weng, A
    Howatson, SR
    Goodlad, JR
    Patel, MC
    Gupta, G
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (02) : 349 - 352
  • [4] Diagnosing erythrodermic cutaneous T-cell lymphoma
    Russell-Jones, R
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (01) : 1 - 5
  • [5] On the diagnosis of erythrodermic cutaneous T-cell lymphoma
    Vonderheid, EC
    JOURNAL OF CUTANEOUS PATHOLOGY, 2006, 33 : 27 - 42
  • [6] Thymic localization of erythrodermic cutaneous T-cell lymphoma
    Bonnet, P.
    Battistella, M.
    Bouaziz, J. -D.
    Ram-Wolff, C.
    Frumholtz, L.
    Herms, F.
    Clerc, G.
    Bonhomme, A.
    Brice, P.
    Bagot, M.
    de Masson, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (02) : 427 - 428
  • [7] Diagnosis, prognosis and management of erythrodermic cutaneous T-cell lymphoma
    Moriarty, Blaithin
    Whittaker, Sean
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (02) : 159 - 171
  • [8] Comment on B ratings for erythrodermic cutaneous T-cell lymphoma
    Vonderheid, Eric
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : 281 - 283
  • [9] TREATMENT OF ERYTHRODERMIC CUTANEOUS T-CELL LYMPHOMA WITH EXTRACORPOREAL PHOTOCHEMOTHERAPY
    HEALD, P
    ROOK, A
    PEREZ, M
    WINTROUB, B
    KNOBLER, R
    JEGASOTHY, B
    GASPARRO, F
    BERGER, C
    EDELSON, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 27 (03) : 427 - 433
  • [10] Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma
    Scarisbrick, JJ
    Whittaker, S
    Evans, AV
    Fraser-Andrews, EA
    Child, FJ
    Dean, A
    Russell-Jones, R
    BLOOD, 2001, 97 (03) : 624 - 630